Sophoridine
AlkaPlorer ID: AK001775
Synonym: None
IUPAC Name: (1R,2R,9R,17S)-7,13-diazatetracyclo[7.7.1.02,7.013,17]heptadecan-6-one
Structure
SMILES: O=C1CCC[C@@H]2[C@H]3CCCN4CCC[C@H](CN12)[C@@H]34
InChI: InChI=1S/C15H24N2O/c18-14-7-1-6-13-12-5-3-9-16-8-2-4-11(15(12)16)10-17(13)14/h11-13,15H,1-10H2/t11-,12-,13-,15+/m1/s1
InChIKey: ZSBXGIUJOOQZMP-BHPKHCPMSA-N
Reference
PubChem CID: 165549
CAS: 519-02-8
LOTUS: LTS0197191
SuperNatural Ⅲ: SN0478798-02
NPASS: NPC48448
Source
Properties Information
Molecule Weight: 248.36999999999995
TPSA?: 23.550000000000004
MolLogP?: 1.8717
Number of H-Donors: 0
Number of H-Acceptors: 2
RingCount: 4
Activities Information
| Organism | Target Name | Standard Type | Standard Value | Standard Units | doi |
|---|---|---|---|---|---|
| Enterovirus A71 | Enterovirus A71 | Activity | nan | None | 10.1016/j.bmcl.2015.06.097 |
| Hepatitis B virus | Hepatitis B virus | Inhibition | 21.9 | % | 10.1021/acs.jnatprod.8b00576 |
| Hepatitis B virus | Hepatitis B virus | Inhibition | 40.2 | % | 10.1021/acs.jnatprod.8b00576 |
| Homo sapiens | A549 | IC50 | 80000.0 | nM | 10.1016/j.bmcl.2015.09.010 |
| Homo sapiens | A549 | IC50 | 5836000.0 | nM | 10.1016/j.ejmech.2018.07.028 |
| Homo sapiens | CNE-2 | IC50 | 5379000.0 | nM | 10.1016/j.ejmech.2018.07.028 |
| Homo sapiens | DNA topoisomerase I | Inhibition | nan | % | 10.1016/j.bmcl.2011.07.038 |
| Homo sapiens | HeLa | IC50 | 4332000.0 | nM | 10.1016/j.bmc.2018.07.001 |
| Homo sapiens | HepG2 | Activity | 0.97 | g | 10.1016/j.ejmech.2018.07.028 |
| Homo sapiens | HepG2 | Activity | 1204.27 | mm3 | 10.1016/j.ejmech.2018.07.028 |
| Homo sapiens | HepG2 | Activity | nan | None | 10.1016/j.ejmech.2018.07.028 |
| Homo sapiens | HepG2 | Activity | nan | None | 10.1021/ml500289h |
| Homo sapiens | HepG2 | IC50 | 20.0 | ug.mL-1 | 10.1016/j.ejmech.2014.04.069 |
| Homo sapiens | HepG2 | IC50 | 1160.0 | ug.mL-1 | 10.1016/j.bmcl.2015.08.035 |
| Homo sapiens | HepG2 | IC50 | 80000.0 | nM | 10.1021/ml500289h |
| Homo sapiens | HepG2 | IC50 | 4509000.0 | nM | 10.1016/j.bmc.2018.07.001 |
| Homo sapiens | HepG2 | IC50 | 4670000.0 | nM | 10.1016/j.ejmech.2018.07.028 |
| Homo sapiens | HepG2 | IC50 | 4670000.0 | nM | 10.1016/j.ejmech.2018.08.021 |
| Homo sapiens | HepG2 | Inhibition | 13.8 | % | 10.1016/j.bmcl.2011.07.038 |
| Homo sapiens | HepG2 | Ratio | 1.22 | None | 10.1016/j.ejmech.2020.112315 |
| Homo sapiens | HepG2 | T/C | 93.38 | % | 10.1016/j.ejmech.2018.07.028 |
| Homo sapiens | HepG2 | TGI | nan | None | 10.1016/j.ejmech.2018.08.021 |
| Homo sapiens | HepG2 2.2.15 | GI | 25.0 | % | 10.1021/acs.jnatprod.8b00576 |
| Homo sapiens | KB | IC50 | 80000.0 | nM | 10.1016/j.bmcl.2015.09.010 |
| Homo sapiens | MCF7 | IC50 | 80000.0 | nM | 10.1016/j.bmcl.2015.09.010 |
| Homo sapiens | MDA-MB-231 | IC50 | 80000.0 | nM | 10.1016/j.bmcl.2015.09.010 |
| Mus musculus | Mus musculus | Activity | nan | None | 10.1016/j.bmcl.2015.06.097 |
| None | NON-PROTEIN TARGET | IC50 | 80000.0 | nM | 10.1016/j.bmcl.2015.09.010 |
